AI drug discovery accelerates with specialized models and breakthroughs [developing]
Key Questions
What breakthrough did Isomorphic Labs achieve in OCD drug development?
Isomorphic Labs, spun out of Google DeepMind, designed a drug for OCD using AI in just 12 months, significantly faster than the usual process. The company is in talks to raise over $2 billion in funding.
What is OpenAI's GPT-Rosalind model?
GPT-Rosalind is an OpenAI model specialized in biochemistry, genomics, and protein research. It supports accelerated AI drug discovery by focusing on vertical foundation models with high ROI in biotech.
How is Roche advancing AI in biotech diagnostics?
Roche plans a billion-dollar acquisition of a US AI pathology firm to integrate into its diagnostics unit. The technology will be rolled out globally, increasing competition in AI-driven biotech.
OpenAI GPT-Rosalind biochem/genomics/protein; Isomorphic $2B+ raise/OCD drug 12mo; vertical FMs high-ROI biotech.
Sources (2)
Updated May 11, 2026